Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
NanoViricides (NNVC)
:NNVC
Holding NNVC?
Track your performance easily
NNVC Stock Chart & Stats
Day’s Range― - ―
52-Week Range$1.01 - $3.59
Previous CloseN/A
Volume409.80K
Average Volume (3M)439.59K
Market Cap
$19.37M
Enterprise Value$16.71M
Total Cash (Recent Filing)$15.10M
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta1.13
Next Earnings
Nov 24, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.76
Shares Outstanding14,347,000
10 Day Avg. Volume715,928
30 Day Avg. Volume439,586
Standard Deviation0.77
R-Squared0.00381
Alpha0.07
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-1.90
P/FCF Ratio0.00
Enterprise Value/Market Cap0.86
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/Ebitda-1.89
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
NanoViricides News
Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
4.57% Mutual Funds
1.59% Other Institutional Investors
90.31% Public Companies and Individual Investors
NNVC FAQ
What was NanoViricides’s price range in the past 12 months?
NanoViricides lowest stock price was $1.01 and its highest was $3.59 in the past 12 months.
What is NanoViricides’s market cap?
NanoViricides’s market cap is $19.37M.
When is NanoViricides’s upcoming earnings report date?
NanoViricides’s upcoming earnings report date is Nov 24, 2025 which is in 314 days.
How were NanoViricides’s earnings last quarter?
NanoViricides released its earnings results on Nov 18, 2024. The company reported -$0.228 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.228.
Is NanoViricides overvalued?
According to Wall Street analysts NanoViricides’s price is currently Overvalued.
Does NanoViricides pay dividends?
NanoViricides does not currently pay dividends.
What is NanoViricides’s EPS estimate?
NanoViricides’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does NanoViricides have?
NanoViricides has 14,347,000 shares outstanding.
What happened to NanoViricides’s price movement after its last earnings report?
NanoViricides reported an EPS of -$0.228 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 4.878%.
Which hedge fund is a major shareholder of NanoViricides?
Currently, no hedge funds are holding shares in NNVC
---
Company Description
NanoViricides
NanoViricides, Inc. is a development stage company, which engages in the development of nanomedicine drugs against viruses. It focuses on anti-viral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs. The company was founded by Anil R. Diwan on April 1, 2005 and is headquartered in Shelton, CT.
---
Technical Analysis
---